Circulating tumor cells(CTCs),as important liquid biopsy target,can provide valuable information for cancer progress monitoring and individualized treatment.However,current isolation platforms incapable of balancing c...Circulating tumor cells(CTCs),as important liquid biopsy target,can provide valuable information for cancer progress monitoring and individualized treatment.However,current isolation platforms incapable of balancing capture efficiency,specificity,cell viability,and gentle release have restricted the clinical applications of CTCs.Herein,inspired by the structure and functional merits of natural membrane interfaces,we established an antibody-engineered red blood cell(RBC-Ab)affinity interface on microfluidic chip for high-performance isolation and release of CTCs.The lateral fluidity,pliability,and anti-adhesion property of the RBC microfluidic interface enabled efficient CTCs capture(96.5%),high CTCs viability(96.1%),and high CTCs purity(average 4.2-log depletion of leukocytes).More importantly,selective lysis of RBCs by simply changing the salt concentration was utilized to destroy the affinity interface for efficient and gentle release of CTCs without nucleic acid contamination.Using this chip,CTCs were successfully detected in colon cancer samples with 90%sensitivity and 100%specificity(20 patients and 10 healthy individuals).After the release process,KRAS gene mutations of CTCs were identified from all the 5 cancer samples,which was consistent with the results of tissue biopsy.We expect this RBC interface strategy will inspire further biomimetic interface construction for rare cell analysis.展开更多
Photoelectrochemical(PEC)active interfaces exhibiting visible-light responses and good electron-transfer ca-pabilities are key to the development of PEC biosensors.In this study,bioinspired polydopamine(PDA)-polyethyl...Photoelectrochemical(PEC)active interfaces exhibiting visible-light responses and good electron-transfer ca-pabilities are key to the development of PEC biosensors.In this study,bioinspired polydopamine(PDA)-polyethyleneimine(PEI)hybrid films were designed to engineer inorganic semiconductors and construct PEC biosensing interfaces.The charge-transfer capability and visible-light-response property of PDA were combined with the electron-attracting ability of PEI to produce a synergistic PEC-enhancement effect.The achieved PEC-enhancement effect was versatile for photoanode and photocathode semiconductors.Further,the role of PEI doping was revealed via electrochemical investigations.Compared with the PDA sensing platform,the hybrid sensing interface offered by the PDA-PEI film exhibited enhanced analytical performances toward ascorbic acid(AA),achieving a larger detection range and a lower limit of detection.展开更多
基金the National Natural Science Foundation of China(21775128,21974113,21735004,21974112,and 21874089)National Key R&D Program of China(2019YFA0905800)+2 种基金Program for Chang Jiang Scholars and Innovative Research Teams in University(IRT13036)Medical and Health Program of Xiamen(3502Z20189005)the National Science Fund for Fostering Talents in Basic Science(NFFTBS,J1310024)for their financial support.
文摘Circulating tumor cells(CTCs),as important liquid biopsy target,can provide valuable information for cancer progress monitoring and individualized treatment.However,current isolation platforms incapable of balancing capture efficiency,specificity,cell viability,and gentle release have restricted the clinical applications of CTCs.Herein,inspired by the structure and functional merits of natural membrane interfaces,we established an antibody-engineered red blood cell(RBC-Ab)affinity interface on microfluidic chip for high-performance isolation and release of CTCs.The lateral fluidity,pliability,and anti-adhesion property of the RBC microfluidic interface enabled efficient CTCs capture(96.5%),high CTCs viability(96.1%),and high CTCs purity(average 4.2-log depletion of leukocytes).More importantly,selective lysis of RBCs by simply changing the salt concentration was utilized to destroy the affinity interface for efficient and gentle release of CTCs without nucleic acid contamination.Using this chip,CTCs were successfully detected in colon cancer samples with 90%sensitivity and 100%specificity(20 patients and 10 healthy individuals).After the release process,KRAS gene mutations of CTCs were identified from all the 5 cancer samples,which was consistent with the results of tissue biopsy.We expect this RBC interface strategy will inspire further biomimetic interface construction for rare cell analysis.
基金the Shandong Provincial Natural Science Foundation(ZR2020YQ13)a Project of Shandong Province Higher Educational Youth Innovation Science and Technology Program(2020KJC008)Jinan Scientific Research Leader Workshop Project(2020GXRC048).
文摘Photoelectrochemical(PEC)active interfaces exhibiting visible-light responses and good electron-transfer ca-pabilities are key to the development of PEC biosensors.In this study,bioinspired polydopamine(PDA)-polyethyleneimine(PEI)hybrid films were designed to engineer inorganic semiconductors and construct PEC biosensing interfaces.The charge-transfer capability and visible-light-response property of PDA were combined with the electron-attracting ability of PEI to produce a synergistic PEC-enhancement effect.The achieved PEC-enhancement effect was versatile for photoanode and photocathode semiconductors.Further,the role of PEI doping was revealed via electrochemical investigations.Compared with the PDA sensing platform,the hybrid sensing interface offered by the PDA-PEI film exhibited enhanced analytical performances toward ascorbic acid(AA),achieving a larger detection range and a lower limit of detection.